Fig. 8From: Development of keratin nanoparticles for controlled gastric mucoadhesion and drug releaseTurbidity of keratins–PGM solution after addition of different inhibitors of chemical interactions (n = 6). **P < 0.01, *P < 0.05 vs. control groupBack to article page